These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6556949)

  • 1. Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma. Correlation between direct and antibody-dependent cell-mediated cytotoxicity.
    Hansson Y; Paulie S; Larsson A; Lundblad ML; Perlmann P; Näslund I
    Cancer Immunol Immunother; 1983; 16(1):23-9. PubMed ID: 6556949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls.
    Troye M; Hansson Y; Paulie S; Perlmann P; Blomgren H; Johansson B
    Int J Cancer; 1980 Jan; 25(1):45-51. PubMed ID: 7399744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
    Troye M; Vilien M; Pape GR; Perlmann P
    Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
    Schneider MU; Troye M; Paulie S; Perlmann P
    Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral in vitro cytotoxicity against autologous bladder tumor cells in humans. Differences in autologous cytotoxicity against non-invasive and invasive transitional-cell tumors of the urinary bladder.
    Jacobsen F
    Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):235-9. PubMed ID: 7315359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
    Perlmann P; Troye M; Pape G; Blomgren H; Johansson B
    Urol Res; 1978; 6(4):207-9. PubMed ID: 741533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of antibodies to cellular antigens by EBV-transformed lymphocytes from patients with urinary bladder carcinoma.
    Paulie S; Lundblad ML; Hansson Y; Koho H; Ben-Aissa H; Perlmann P
    Scand J Immunol; 1984 Nov; 20(5):461-70. PubMed ID: 6095441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators.
    Moroz C; Madgar I; Twig S; Lindner A; Many M
    Int J Cancer; 1982 Jun; 29(6):667-72. PubMed ID: 6980847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
    Mai KT; Yazdi HM; Farmer J
    Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
    Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
    Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A follow-up study of urinary bladder patients tested for tumour-related lymphocyte-mediated cytotoxicity.
    Larsson A; Näslund I; Troye M
    Cancer Immunol Immunother; 1982; 14(2):82-5. PubMed ID: 6965230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma.
    O'Toole C
    Int J Cancer; 1977 Mar; 19(3):324-31. PubMed ID: 844912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH
    Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder.
    Hansson Y; Vargas-Cortes M; Paulie S; Perlmann P
    Cancer Immunol Immunother; 1988; 27(3):205-12. PubMed ID: 3263206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anti-ubiquitin antibody response in transitional cell carcinoma of the urinary bladder.
    Ardelt PU; Ebbing J; Adams F; Reiss C; Arap W; Pasqualini R; Bachmann A; Wetterauer U; Riedmiller H; Kneitz B
    PLoS One; 2015; 10(3):e0118646. PubMed ID: 25742283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma membrane-associated antigens on tumor cells derived from transitional-cell carcinoma of the human urinary bladder. II. Identification at the molecular level of plasma membrane-associated antigens.
    Schneider MU; Paulie S; Troye M; Perlmann P
    Int J Cancer; 1980 Aug; 26(2):193-202. PubMed ID: 7203713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunity to transitional cell carcinoma of the urinary bladder. III. Effects of hydrostatic pressure therapy.
    O'Toole C; Helmstein K; Perlmann P; Moberger G
    Int J Cancer; 1975 Sep; 16(3):413-26. PubMed ID: 1176202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.